Semaglutide Helps Prevent Kidney Damage in People with Obesity
A new study finds semaglutide, the active ingredient in Ozempic and Wegovy, reduced kidney damage by up to 52% in people with obesity.
Health News is provided as a service to Martin's Pharmacy #203 site users by HealthDay. Martin's Pharmacy #203 nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.